Induction of the TEAD co-activator VGLL1 by estrogen receptor-targeted therapy drives resistance in breast cancer

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.